0.2555

11.28% -0.0325

After Hours: .26 0.0045 +1.76%

Co Diagnostics Inc (CODX)

Overview News Price History Option Chain Financials Discussions Forecast

Co Diagnostics Inc stock is traded at $0.2555, with a volume of 1.59M. It is down -11.28% in the last 24 hours and down -28.67% over the past month. Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Previous Close:

$0.288

Open:

$0.2934

24h Volume:

1.59M

Relative Volume:

4.99

Market Cap:

$8.61M

Revenue:

$7.11M

Net Income/Loss:

$-41.28M

P/E Ratio:

-0.1851

EPS:

-1.38

Net Cash Flow:

$-26.84M

1W Performance:

+10.32%

1M Performance:

-28.67%

6M Performance:

-71.32%

1Y Performance:

-75.67%

1-Day Range:

$0.25

$0.335

1-Week Range:

$0.23

$0.335

52-Week Range:

$0.2275

$2.2299

Co Diagnostics Inc Stock (CODX) Company Profile

Name

Co Diagnostics Inc

Sector

Healthcare (1170)

Industry

Medical Devices (155)

Phone

(801) 278-9769

Address

4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY

Employee

132

Twitter

@Co_Diagnostics

Next Earnings Date

2024-11-07

Latest SEC Filings

CODX's Discussions on Twitter

Compare CODX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CODX Co Diagnostics Inc	0.2555	7.81M	7.11M	-41.28M	-26.84M	-1.38
ABT Abbott Laboratories	133.58	228.44B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	105.26	154.60B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	382.64	143.93B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	82.98	103.43B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	78.22	43.99B	5.54B	4.18B	623.10M	7.00

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-12-22	Downgrade	Sidoti	Buy → Neutral
Dec-29-21	Initiated	Sidoti	Buy
Mar-29-21	Downgrade	Maxim Group	Buy → Hold
May-20-20	Upgrade	Maxim Group	Hold → Buy
May-18-20	Reiterated	H.C. Wainwright	Buy
Mar-09-20	Reiterated	H.C. Wainwright	Buy
Mar-03-20	Downgrade	Maxim Group	Buy → Hold

View All

Co Diagnostics Inc Stock (CODX) Latest News

May 29, 2025

Co-Diagnostics Holds Annual Shareholders Meeting - TipRanks

May 29, 2025

May 21, 2025

Co-Diagnostics stock hits 52-week low at $0.27 amid market challenges - Investing.com Australia

May 21, 2025

May 15, 2025

HC Wainwright Predicts Co-Diagnostics Q1 Earnings - Defense World

May 15, 2025

Q2 EPS Estimates for Co-Diagnostics Raised by HC Wainwright - Defense World

May 15, 2025

May 14, 2025

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference | CODX Stock News - GuruFocus

May 14, 2025

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference - The Manila Times

May 14, 2025

Co-Diagnostics, Inc. to Participate in D. Boral Capital Inaugural Global Conference on May 14, 2025 - Nasdaq

May 14, 2025

Co-Diagnostics Unveils Next-Gen PCR Testing Platform to Elite Institutional Investors - Stock Titan

May 14, 2025

May 10, 2025

Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025

May 09, 2025

Earnings call transcript: Co-Diagnostics Q1 2025 shows improved EPS and revenue decline - Investing.com Nigeria

May 09, 2025